UK pharma04 Aug
AstraZeneca is in $400bn merger talks. Will there be a deal by the end of August?
AstraZeneca has been in talks for months with Bristol Myers Squibb on a $400bn merger, the FT reported on 2 August. Its shares fell as much as 7%.
2 of 5Two of the last five leaked UK pharma megadeals produced an agreed offer, and all five reached a definitive answer inside six weeks.
Do AstraZeneca and Bristol Myers Squibb announce an agreed merger by 31 Aug 2026?
History2 of 5Hunch40%